Price Chart

No data available
DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
             
             
             
             
             
             
             
             

Earnings

Next Report Date --
EPS Estimate Upgrade
Last Actual EPS Upgrade
 
4.00
2.00
1.00
 
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
No data available
Last Report Date --
Beat/Miss Upgrade
Return Since --
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
CBD Unlimited Inc develops CBD-based products. It sells high-end, full-spectrum CBD oils, capsules, topicals, and pet products, to support the therapeutic relief of pain and inflammation for humans and pets, through its e-commerce site and other online and in-store retailers. Its Gorilla-Tek division offers an automated dispensing system providing a secure method of distributing hemp-based products. It also owns and operates subsidiaries that offer technology and consulting solutions to the hemp and CBD industry, including an easy-to-use Seed-to-Shelf compliance and inventory tracking and process management system for regulated products in a front of counter pharmacy support platform.
URL https://www.cbdunlimited.com
Investor Relations URL N/A
HQ State/Province Arizona
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style N/A
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-48.92%
148.7%
48.62%
-29.28%
92.31%
10.26%
-70.41%
171.3%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-19.50%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-71.32%
-9.04%
-23.93%
70.05%
-17.52%
10.42%
-13.60%
-24.30%
-51.92%
-18.25%
-29.46%
-55.16%
-57.46%
-66.95%
321.7%
-47.71%
-67.81%
56.85%
-66.70%
-33.39%
-96.85%
-9.48%
-24.44%
-28.93%
-61.79%
As of October 04, 2022.

Profile

Edit
CBD Unlimited Inc develops CBD-based products. It sells high-end, full-spectrum CBD oils, capsules, topicals, and pet products, to support the therapeutic relief of pain and inflammation for humans and pets, through its e-commerce site and other online and in-store retailers. Its Gorilla-Tek division offers an automated dispensing system providing a secure method of distributing hemp-based products. It also owns and operates subsidiaries that offer technology and consulting solutions to the hemp and CBD industry, including an easy-to-use Seed-to-Shelf compliance and inventory tracking and process management system for regulated products in a front of counter pharmacy support platform.
URL https://www.cbdunlimited.com
Investor Relations URL N/A
HQ State/Province Arizona
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style N/A
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter EDXC Tweets